BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Japan

Eisai and EcoNaviSta Join Forces to Develop Dementia Ecosystem in Japan’s Super-Aging Society

Eisai Co., Ltd. and EcoNaviSta Inc. announced that they have entered into a business alliance agreement and commenced collaboration with the aim of buildin...

July 25, 2024 | News

National Cancer Center and University of Pennsylvania License CCR4 CAR-T Cell Therapy to ARC Therapies Inc.

The National Cancer Center (Tokyo, Japan) and The University of Pennsylvania (Philadelphia, PA, USA) have licensed patent rights directed to a ch...

July 12, 2024 | News

Calliditas Therapeutics and Viatris Initiate Phase III Trial for IgA Nephropathy in Japan

Calliditas Therapeutics AB announces that its partner Viatris Pharmaceutical Japan G.K. ("Viatris") has initiated a phase III clinical trial in&...

July 05, 2024 | News

Eisai Reclaims Full Rights to Farletuzumab Ecteribulin After Ending Collaboration with Bristol Myers Squibb

Eisai Co., Ltd. announced that it has agreed to end its global strategic collaboration with Bristol Myers Squibb for the co-development and c...

July 04, 2024 | News

KORU Medical Systems' FreedomEdge® System Gains Regulatory Clearance in Japan for Advanced Subcutaneous Infusion Therapies

KORU Medical Systems,a leading medical technology company focused on development, manufacturing, and commercialization of innovative and patient-centric la...

July 03, 2024 | News

MEDIPAL and JCR Pharmaceuticals Announce Regulatory Review Completion for Phase I/II Trial of JR-446 in Treating Ultra-Rare Sanfilippo Syndrome Type B

MEDIPAL HOLDINGS CORPORATION and JCR Pharmaceuticals Co., Ltd. announced the completion of the regulatory review by the Pharmaceuticals an...

July 03, 2024 | News

ValGenesis Partners with Validator K.K. to Revolutionize Validation Services in Japanese Life Sciences Sector

ValGenesis, Inc., the market leader in enterprise validation lifecycle management systems (VLMS), and Validator K.K., a reputed Japanese validation product...

July 03, 2024 | News

HiRO Acquires DeltaMed Solutions, Expands Across 10 Countries

Harvest Integrated Research Organization (HiRO), a full-service, boutique global CRO, is excited to announce its latest strategic move with the successful ...

July 02, 2024 | News

Asahi Kasei Launches Innovative Membrane System for WFI Production, Reducing CO2 Emissions and Costs

Asahi Kasei has announced that in April 2024 it began selling a membrane system to produce WFI (water for injection), a type of sterile water that is ...

June 14, 2024 | News

Luye Pharma and Towa Pharmaceutical File NDA in Japan for Rivastigmine Twice Weekly Patch for Alzheimer’s

Luye Pharma Group announced that its partner Towa Pharmaceutical Co., Ltd. (Towa) has filed a New Drug Application (NDA) to the Ministry of Health, Labour ...

June 07, 2024 | News

Eisai Co., Ltd. Expands Venture Investment to Accelerate Drug Discovery Innovation

Eisai Co., Ltd. announced that the company decided to strengthen and continue its venture investment business, which launched in 2019, with the aim of disc...

June 04, 2024 | News

Eisai Co., Ltd. Expands Venture Investment to Accelerate Drug Discovery Innovation

Eisai Co., Ltd. announced that the company decided to strengthen and continue its venture investment business, which launched in 2019, with the aim of disc...

June 04, 2024 | News

Takara Bio Inc. Launches Large-Scale Viral Vector Manufacturing with Thermo Fisher’s DynaDrive Bioreactors

Thermo Fisher Scientific in Japan is pleased to announce that, as of 22 April 2024, Takara Bio Inc. has begun large-scale viral vector contract manufacturi...

May 30, 2024 | News

Hitachi High-Tech and Roche Extend Partnership for Another Decade

Hitachi High-Tech Corporation ("Hitachi High-Tech") announced that Roche and Hitachi High-Tech have extended their partnership, committing to at least 10...

May 28, 2024 | News

Stay Connected